Status:
NOT_YET_RECRUITING
Evaluation of Outcomes With Umbilical Cord Allograft for Musculoskeletal Conditions Musculoskeletal Conditions
Lead Sponsor:
R3 Stem Cell
Conditions:
Osteoarthritis
Tendinitis
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The aim of the study is to determine the efficacy of an Amniotic Fluid Tissue Product for pain relief and functional improvements for all types of musculoskeletal conditions. The study is prospective,...
Detailed Description
Medical providers are often faced with patients whose source of pain may be the result of an inflammatory response caused by trauma or disease. By managing the patient's inflammation, the clinician ma...
Eligibility Criteria
Inclusion
- Age 18 and over.
- Ability to attend follow up visits or at least converse on phone or complete email follow up forms.
- 4\) Competent to understand the study protocol and provide voluntary informed consent.
Exclusion
- Active Infection
- Pregnancy, Lactating
- Clotting disorder
Key Trial Info
Start Date :
January 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
January 1 2030
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT03390920
Start Date
January 1 2022
End Date
January 1 2030
Last Update
September 17 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Advanced Stem Cell Institute
Encino, California, United States, 91316